Inflammatory bowel disease in pregnancy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 22

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

413

HTML

3200

Tables (1-1)

148

Sum=3761

Jun 14, 2011 (publication date) through Apr 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jun 14, 2011; 17(22): 2696-2701
Published online Jun 14, 2011. doi: 10.3748/wjg.v17.i22.2696

Table 1 Use of medications during pregnancy in inflammatory bowel disease

Benefit clearly outweighs risk	Limited data	Contraindicated
5-ASA, oral and topical	Olsalazine	Methotrexate
Corticosteroids	Natalizumab	Thalidomide
Metronidazole, amoxicillin
Azathioprine/6-MP
Anti-TNF agents

TNF: Tumor necrosis factor.

Citation: Beaulieu DB, Kane S. Inflammatory bowel disease in pregnancy. World J Gastroenterol 2011; 17(22): 2696-2701
URL: https://www.wjgnet.com/1007-9327/full/v17/i22/2696.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i22.2696